Focus: Achieve Life Sciences is a public biotech company focused on small-molecule oncology and smoking cessation therapies. With $13M in cash and $30M in R&D spend (FY 2024), the company is a clinical-stage player pursuing late-phase programs in high-unmet-need areas.
Profile data last refreshed 16h ago · AI intelligence enriched 2mo ago
Stable — net -1 jobs in 30d
2 added, 3 removed. Backfill posture.
Achieve is a high-risk/high-reward clinical-stage play with a credible smoking-cessation bet and oncology pipeline, but severe cash constraints and pre-revenue status make this a 2–3 year make-or-break inflection point for job seekers.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Achieve Life Sciences
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Achieve Life Sciences's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
+2 more
+2 more
+2 more
+2 more
Seven new employees receive stock awards from Achieve Life Sciences - Stock Titan
Seven new employees receive stock awards from Achieve Life Sciences Stock Titan
Achieve Life Sciences Announced Granting of New Hire Inducement Awards - finance.yahoo.com
Achieve Life Sciences Announced Granting of New Hire Inducement Awards finance.yahoo.com
Achieve Life Sciences Announced Granting of New Hire Inducement Awards - GlobeNewswire
Achieve Life Sciences Announced Granting of New Hire Inducement Awards GlobeNewswire
This Insider Has Just Sold Shares In Achieve Life Sciences - simplywall.st
This Insider Has Just Sold Shares In Achieve Life Sciences simplywall.st
Achieve Life Sciences, Inc. (NASDAQ:ACHV): Is Breakeven Near? - simplywall.st
Achieve Life Sciences, Inc. (NASDAQ:ACHV): Is Breakeven Near? simplywall.st
Achieve Life Sciences Q2 2026 Earnings: Revenue N/A (Pre-Revenue) as EPS Misses $0.16 Consensus - technotrenz.com
Achieve Life Sciences Q2 2026 Earnings: Revenue N/A (Pre-Revenue) as EPS Misses $0.16 Consensus technotrenz.com
Showing 6 of 10 news items
Based on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub
Recent peer-reviewed publications with author affiliations at this company
Receptor selectivity of cytisinicline: minimal 5-HT3 binding may explain lower incidence of nausea in smoking cessation therapy.
Cytisinicline for smoking cessation in individuals with self-reported COPD: a post hoc analysis of the ORCA-2 and ORCA-3 trials.
Showing 5 of 9 publications
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo